T1	p 23 39	asthma in adults
T2	p 230 310	31 adult asthmatic patients in a double-blind crossover trial lasting 12 weeks .
T3	i 46 87	sodium cromoglycate pressurized aerosol :
T4	i 122 177	Sodium cromoglycate formulated as a pressurized aerosol
T5	i 201 212	and placebo
T6	i 311 330	Sodium cromoglycate
T7	i 347 354	placebo
T8	i 769 790	sodium cromoglycate .
T9	i 827 841	( theophylline
T10	i 933 952	sodium cromoglycate
T11	i 975 984	placebo .
T12	i 1053 1105	sodium cromoglycate delivered by pressurized aerosol
T13	i 1136 1143	placebo
T14	o 368 390	breathlessness at rest
T15	o 415 441	breathlessness on exertion
T16	o 471 487	quality of sleep
T17	o 538 577	morning peak expiratory flow rate value
T18	o 715 736	treatment preferences
T19	o 802 826	usage of bronchodilators
T20	o 988 1000	side-effects
T21	o 1168 1186	asthmatic symptoms
T22	o 1214 1269	amount of concomitant bronchodilator therapy required .